Thermo Fisher Scientific Statistics

Total Valuation

Thermo Fisher Scientific has a market cap or net worth of GBP 183.94 billion. The enterprise value is 204.72 billion.

Market Cap	183.94B
Enterprise Value	204.72B

Important Dates

The last earnings date was Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Dec 13, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.29%
Shares Change (QoQ)	-0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	381.69M

Valuation Ratios

The trailing PE ratio is 36.35.

PE Ratio	36.35
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.53, with an EV/FCF ratio of 35.27.

EV / Earnings	40.46
EV / Sales	5.93
EV / EBITDA	23.53
EV / EBIT	32.99
EV / FCF	35.27

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.63.

Current Ratio	1.66
Quick Ratio	1.03
Debt / Equity	0.63
Debt / EBITDA	2.88
Debt / FCF	4.30
Interest Coverage	5.58

Financial Efficiency

Return on equity (ROE) is 13.13% and return on invested capital (ROIC) is 5.89%.

Return on Equity (ROE)	13.13%
Return on Assets (ROA)	4.94%
Return on Invested Capital (ROIC)	5.89%
Return on Capital Employed (ROCE)	9.23%
Revenue Per Employee	280,741
Profits Per Employee	41,477
Employee Count	122,000
Asset Turnover	0.44
Inventory Turnover	4.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.47% in the last 52 weeks. The beta is 0.79, so Thermo Fisher Scientific's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+5.47%
50-Day Moving Average	539.20
200-Day Moving Average	570.44
Relative Strength Index (RSI)	68.57
Average Volume (20 Days)	1,650

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.72

Income Statement

In the last 12 months, Thermo Fisher Scientific had revenue of GBP 34.25 billion and earned 5.06 billion in profits. Earnings per share was 13.20.

Revenue	34.25B
Gross Profit	14.46B
Operating Income	6.19B
Pretax Income	5.59B
Net Income	5.06B
EBITDA	8.67B
EBIT	6.19B
Earnings Per Share (EPS)	13.20

Full Income Statement

Balance Sheet

The company has 4.45 billion in cash and 24.98 billion in debt, giving a net cash position of -20.53 billion.

Cash & Cash Equivalents	4.45B
Total Debt	24.98B
Net Cash	-20.53B
Net Cash Per Share	n/a
Equity (Book Value)	39.68B
Book Value Per Share	103.61
Working Capital	7.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.92 billion and capital expenditures -1.12 billion, giving a free cash flow of 5.80 billion.

Operating Cash Flow	6.92B
Capital Expenditures	-1.12B
Free Cash Flow	5.80B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 42.23%, with operating and profit margins of 18.09% and 14.77%.

Gross Margin	42.23%
Operating Margin	18.09%
Pretax Margin	16.31%
Profit Margin	14.77%
EBITDA Margin	25.32%
EBIT Margin	18.09%
FCF Margin	16.95%

Dividends & Yields

This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 0.20%.

Dividend Per Share	1.22
Dividend Yield	0.20%
Dividend Growth (YoY)	8.84%
Years of Dividend Growth	8
Payout Ratio	9.20%
Buyback Yield	1.29%
Shareholder Yield	1.49%
Earnings Yield	2.75%
FCF Yield	3.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a